AshiBio
Cambridge, United States · Founded 2022 · $40.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- ashibio.com
- Total Funding
- $40.0M
- Last Round
- $40.0M Series AJun 2024
- Rounds
- 1
About
Clinical-stage biotech developing novel therapeutics for bone and connective tissue disorders.
Summary
AshiBio is a Biotech company based in Cambridge, United States, founded in 2022. It has raised $40.0M in total across 1 round, most recently a $40.0M Series A round in Jun 2024. Investors include MPM BioImpact, Agent Capital and YK Bioventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company